The Cancer Survivors Network (CSN) is a peer support community for cancer patients, survivors, caregivers, families, and friends! CSN is a safe place to connect with others who share your interests and experiences.

Thank you for being a part of the Cancer Survivor Network community. Survivors and caregivers like you have played a unique role in fostering an online environment that encourages connection among those needing support, community, and education. On May 28, the Network will be discontinued. More details are available here . If you have any questions, contact CSNSupportTeam@cancer.org. Thanks again for the support you’ve provided each other over the years. We remain committed to supporting you in other ways throughout your cancer journey.

(11)C-Choline PET/CT and PSA kinetics - Abstract

hopeful and optimistic
hopeful and optimistic CSN Member Posts: 2,347 Member

(11)C-Choline PET/CT and PSA kinetics - Abstract

 




Published on 24 May 2013



 

 














 




image

 

The role of PET/CT with radiolabelled 18F-choline or 11C-choline in patients with prostate cancer after primary treatment has not been established yet and there are no guidelines on the appropriate use of this emerging modality.

According to the literature, choline PET/CT may have a role in restaging the disease in patients with biochemical relapse for the detection of local and/or lymph node and/or distant recurrence. The aim of this brief review is to summarize the results of the most relevant published studies with particular focus on the relationship between prostate-specific antigen levels and kinetics and the sensitivity of choline PET/CT for optimizing the selection of patients who may benefit the most from this diagnostic procedure, especially early after biochemical recurrence.

Written by: 
Castellucci P, Picchio M.   Are you the author? 
Nuclear Medicine Unit, Policlinico S. Orsola-Malpighi, University of Bologna, Bologna, Italy. paolo.castellucci@aosp.bo.it

Reference: Eur J Nucl Med Mol Imaging. 2013 Apr 12. Epub ahead of print. 
doi: 10.1007/s00259-013-2377-z


PubMed Abstract
PMID: 23579864

UroToday.com Prostate Cancer Section